| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_058e4c932dbfc13eba909846e15d9596 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 |
| filingDate |
2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca33a0313cb915dee0f80591d034863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ab1d483131d6331c1f301da251620e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60793554cda55ce8cdba51ecf31fe2ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42afa64e969120bf6ec517dd5fe83735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef23f5bd38a4f882a1e78d64e9cc409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754b4f85b54b3558f22ffcb0f7d1c835 |
| publicationDate |
2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019212201-A1 |
| titleOfInvention |
Method for isolating dopamine neurons and pharmaceutical composition for treating parkinson's disease, containing dopamine neurons isolated using same |
| abstract |
The present invention relates to a method for isolating dopamine neurons and a pharmaceutical composition for treating Parkinson's disease, containing dopamine neurons isolated using same. The method for isolating dopamine neurons comprises a step for isolating trophoblast glycoprotein (TPBG)-positive dopamine neurons, such that the dopamine neurons isolated by the method have increased cell efficacy when transplanted and enhanced transplantation safety so as to be effectively used for cell transplantation for the treatment of Parkinson's disease. |
| priorityDate |
2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |